|
|
 In 1990 study in San Diego, CA the 5 active subjects with fat allergic rhinitis had a lowered total serum IgE from Day burning 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, product 1 with asthma and 1 with both), had flat or increased IgE levels.4 In a randomized, double-blind, placebo controlled study of symptoms and serum fat IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. Seven of the 10 active treated subjects had a reduction in total serum IgE levels. In 10 placebo treated subjects, 5 had levels of total serum IgE burning that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 Statistical product analysis of the open-label study as well as the double-blind randomized placebo controlled study have shown a significant effect of vitamin B12 in lowering serum IgE concentrations. With no further treatment, the 1996 ten-month follow-up data (n=92) from a high pollen period in Oregon, Washington and Idaho together showed fat a greater reduction in the active group (n=43) than the placebo group (n=49) on the primary endpoint, defined burning as a combination of symptom and rescue medication scores.8 Patients gave blood serum samples prior to the treatment in 1995 product and one year later in 1996. They were immunoassayed for specific IgE antibodies using fat a chemi-luminescent technique. Statistician Bradley Rosebrook ran T-Tests comparing average baseline IgE levels to one-year. For the seasonal burning allergens reported, the active group (n=27) had on average product a greater reduction in IgE than the placebo group (n=34) for 13 out of 16 allergens.8 In January 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin B12. In June 1997, fat the 62 placebo subjects were sent a questionnaire asking: How would you compare your overall allergy (hay fever) symptoms this spring burning to the last two springs? 20 people responded, with 15 reporting having had the B12 product treatment, and 5 not. 12 of the 15 reported at least a slight improvement in overall allergy symptoms, and 1 of the 5. Improvement ratios - 12:3 having received treatment, 1:4 not having received treatment.8 A bioequivalence study showed that a 3000 mcg lozenge delivered an equivalent amount of cyanocobalamin to the blood as a 15 mcg injection.9 From fat the burning spring to the summer patients with demonstrated allergic product rhinitis received with the cyanocobalamin (or placebo) fat containing lozenge twice daily for 21 consecutive days. All subjects also received C and B oral multivitamins for 21 days. Twice daily subjects maintained a nine-week diary on sneezing, runny burning nose, nasal congestion, itchy eyes, product itchy nose and antihistamine (chlorpheniramine) fat use. In the post-treatment period, the active group (n=15) recorded on average a greater reduction burning in symptoms and in antihistamine use than the placebo group (n=9). The results yielded reductions product (0.1>p>0.01) in total weekly symptom/rescue fat medication for the active burning group compared to the placebo for weeks 2, 6, 8 and 9. The results tend to replicate product those of the studies on injectable cyanocobalamin.10 We can help you shred those unwanted pounds! Visit this site to find out how you can reduce your calories, burn fat, and lose weight. Our meal plans won't bust your budget, but they will help you live a healthier life as you lose that unwanted weight. You'll quickly see why our meal plan is the people's favorite.
|